• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

Pharmacovigilance Analytics

Your best resource for PV analytics news, content and innovation!

  • Home
  • Pharmacovigilance Analytics
    • Sources of data
    • Methods and tools
  • Signal Detection and Management in Pharmacovigilance
  • News
  • Opinion
  • About
  • Glossary

Clinical Trial

January 6, 2024 by Jose Rossello

A clinical trial is a research study conducted to evaluate the safety and effectiveness of new medical interventions. These interventions can include drugs, devices, treatments, or strategies for diagnosing, treating, or preventing health conditions. Clinical trials are a critical step in the development of new medical treatments and are essential for advancing medical knowledge and patient care. Here’s an overview:

  1. Purpose: The primary goal of a clinical trial is to gather scientific evidence to establish the safety and efficacy of a new treatment or intervention. This evidence is crucial for regulatory approval and for guiding clinical practice.
  2. Phases of Clinical Trials:
    • Phase I: Tests the safety of a new intervention in a small group of people (usually healthy volunteers) to determine safe dosage ranges and identify side effects.
    • Phase II: Focuses on the effectiveness of the intervention and continues to evaluate its safety. This phase involves a larger group of people who have the condition that the intervention is meant to treat.
    • Phase III: Involves large groups of participants to confirm the intervention’s effectiveness, monitor side effects, compare it to standard or equivalent treatments, and collect information that will allow it to be used safely.
    • Phase IV: Conducted after a treatment has been marketed. These trials gather additional information about the intervention’s risks, benefits, and optimal use.
  3. Types of Clinical Trials:
    • Treatment Trials: Test new treatments, new combinations of drugs, or new approaches to surgery or radiation therapy.
    • Prevention Trials: Look for better ways to prevent disease in people who have never had the disease or to prevent a disease from returning.
    • Diagnostic Trials: Conducted to find better tests or procedures for diagnosing a particular disease or condition.
    • Screening Trials: Test the best way to detect certain diseases or health conditions.
    • Quality of Life Trials (Supportive Care Trials): Explore ways to improve comfort and quality of life for individuals with a chronic illness.
  4. Participant Selection: Participants are often chosen based on specific criteria, such as age, gender, the type and stage of a disease, previous treatment history, and other medical conditions.
  5. Informed Consent: Before joining a clinical trial, participants are given complete information about the study, including potential risks and benefits, and they must provide informed consent, indicating that they understand and agree to participate voluntarily.
  6. Ethical Standards: Clinical trials are conducted in accordance with strict ethical principles and are often overseen by an Institutional Review Board (IRB) or Ethics Committee to ensure that the risks are as low as possible and are worth any potential benefits.
  7. Data Collection and Analysis: Data collected from clinical trials are analyzed to determine whether the intervention is safe and effective. The results are often published in scientific journals and used to inform medical practice and further research.

Clinical trials are essential for developing new and improved treatments and understanding health conditions. They can offer participants early access to new treatments and contribute to the broader scope of medical knowledge.

Related Articles:
  • Signal Analytics Technology in Pharmacovigilance: Enhancing Drug Safety Monitoring
  • Glossary: Case Report Form (CRF)
  • Glossary: Efficacy Evaluation
  • Key IND Enabling Studies: Navigating Preclinical Development Regulations
  • Glossary: Electronic Data Capture (EDC)
Related Terms:
  • Term: Clinical Trial

Primary Sidebar

Subscribe in a reader

Search Website

Uses of Generative AI in Pharmacovigilance

Featured News / Posts

Signal Analytics Technology in Pharmacovigilance

Signal Analytics Technology in Pharmacovigilance: Enhancing Drug Safety Monitoring

Pharmacovigilance plays a crucial role in ensuring public safety by monitoring, … [Read More...] about Signal Analytics Technology in Pharmacovigilance: Enhancing Drug Safety Monitoring

8 Common FDA Applications for Drugs & Biologics

The U.S. Food and Drug Administration (FDA) has several types of applications … [Read More...] about 8 Common FDA Applications for Drugs & Biologics

Key IND Enabling Studies: Navigating Preclinical Development Regulations

Investigational New Drug (IND) applications represent a critical stage in the … [Read More...] about Key IND Enabling Studies: Navigating Preclinical Development Regulations

Pharmacokinetics and Pharmacodynamics (PKPD): Fundamentals in Drug Development and Therapeutic Effectiveness

Pharmacokinetics and pharmacodynamics are two fundamental pillars in the field … [Read More...] about Pharmacokinetics and Pharmacodynamics (PKPD): Fundamentals in Drug Development and Therapeutic Effectiveness

Current Regulations Regarding Reference Safety Information (RSI): Key Aspects and Updates

Regulatory authorities in the pharmaceutical industry have established standards … [Read More...] about Current Regulations Regarding Reference Safety Information (RSI): Key Aspects and Updates

Methods of Statistical Signal Detection in Patient Safety and Pharmacovigilance: Key Techniques and Approaches

In the realm of patient safety and pharmacovigilance, statistical signal … [Read More...] about Methods of Statistical Signal Detection in Patient Safety and Pharmacovigilance: Key Techniques and Approaches

Pharmacovigilance Signal Detection Software: Enhancing Drug Safety and Monitoring

Pharmacovigilance signal detection software plays a crucial role in … [Read More...] about Pharmacovigilance Signal Detection Software: Enhancing Drug Safety and Monitoring

What is a PBRER? Understanding Periodic Benefit-Risk Evaluation Reports

A Periodic Benefit-Risk Evaluation Report (PBRER) serves as a structured … [Read More...] about What is a PBRER? Understanding Periodic Benefit-Risk Evaluation Reports

Drug Safety vs Pharmacovigilance: Exploring Conceptual Differences

Drug safety and pharmacovigilance are crucial aspects of public … [Read More...] about Drug Safety vs Pharmacovigilance: Exploring Conceptual Differences

Which Sections of a DSUR Must Present Safety and Pharmacovigilance Quantitative Data: Key Components Explained

he Development Safety Update Report (DSUR) is a crucial document that serves as … [Read More...] about Which Sections of a DSUR Must Present Safety and Pharmacovigilance Quantitative Data: Key Components Explained

  • What is a DSUR (Development Safety Update Report)? An Essential Guide for Clinical Research
  • What is a BLA (Biologics License Application)? Essential Guide for Professionals
  • What is a PADER? – Periodic Adverse Drug Experience Report Explained

RSS ICH News

  • An error has occurred, which probably means the feed is down. Try again later.

RSS From Nature journal

  • A disproportionality analysis of adverse events associated with ertapenem using the FAERS database from 2004 to 2024
  • Safety comparisons among different subcutaneous anticoagulants for venous thromboembolism using FDA adverse event reporting system
  • Biochemical and hematological reference intervals in rhesus and cynomolgus macaques and implications for vaccine and drug development
  • New insight into teratogenic effects of (S)-thalidomide in zebrafish embryos growing inside the chorion and subjected to electric pulses
  • A microfluidic bone marrow chip for the safety profiling of biologics in pre-clinical drug development

Copyright © 2025 · News Pro on Genesis Framework · WordPress · Log in